RESEARCH USE ONLY (RUO) COA WITH EVERY BATCH ≥99% VERIFIED PURITY FAST USA SHIPPING 3RD-PARTY LAB TESTED

Blend: CJC1295 NO DAC 5mg + Ipamorelin 5mg

Original price was: $157.00.Current price is: $109.90.

PEPLUS Blend: CJC1295 NO DAC 5mg + Ipamorelin 5mg is multi-component peptide research blend supplied in a laboratory vial for qualified research examining CJC 1295 NO DAC: GHRH receptor signaling without a drug-affinity-complex extension; Ipamorelin: growth hormone secretagogue receptor 1a (GHS-R1a). This multi-component presentation is intended for controlled combination-pathway studies. Researchers should evaluate each constituent and the combined system with suitable controls; the presence of multiple compounds does not establish synergy. Professionally packaged and clearly identified for laboratory handling.

For research use only. Not for human consumption.

SKU PEPLUS-BLEND-CJC1295-NO-DAC-5MG-PLUS-IPAMORELIN-5MG Category Tags ,

Product Overview

PEPLUS Blend: CJC1295 NO DAC 5mg + Ipamorelin 5mg is CJC 1295 NO DAC: a synthetic modified GHRH(1-29)-related peptide commonly differentiated from DAC-linked CJC-1295; Ipamorelin: a synthetic ghrelin-receptor agonist. It is classified as multi-component peptide research blend and is presented as a laboratory research material in a clearly identified vial. This multi-component presentation is intended for controlled combination-pathway studies. Researchers should evaluate each constituent and the combined system with suitable controls; the presence of multiple compounds does not establish synergy. PEPLUS catalogue presentation emphasizes professional labeling, consistent product identification, and laboratory-focused handling without making assumptions about a specific experimental protocol. The material is intended for qualified investigators developing appropriately controlled in vitro, analytical, biochemical, or preclinical research models. Product identity, concentration or fill quantity, and any batch-specific characteristics should always be confirmed from the vial label and accompanying documentation before experimental use.

Scientific Background

Cjc 1295 no dac: a synthetic modified ghrh(1-29)-related peptide commonly differentiated from dac-linked cjc-1295; ipamorelin: a synthetic ghrelin-receptor agonist. The established research literature places this material within multi-component peptide research blend research, with particular attention to CJC 1295 NO DAC: GHRH receptor signaling without a drug-affinity-complex extension; Ipamorelin: growth hormone secretagogue receptor 1a (GHS-R1a). This multi-component presentation is intended for controlled combination-pathway studies. Researchers should evaluate each constituent and the combined system with suitable controls; the presence of multiple compounds does not establish synergy. Published investigations in this field commonly compare concentration-response behavior, receptor or enzyme selectivity, downstream signaling, structural stability, and time-dependent cellular responses. The relevance of any observation depends on experimental system, species, cell type, analytical method, and controls. Accordingly, PEPLUS describes this product as a scientific research input rather than a medicine, supplement, diagnostic reagent, or consumer product. Researchers should consult primary literature and institutionally approved methods when selecting assays and interpreting results.

Mechanism and Biochemical Context

Research involving CJC 1295 NO DAC + Ipamorelin commonly examines CJC 1295 NO DAC: GHRH receptor signaling without a drug-affinity-complex extension; Ipamorelin: growth hormone secretagogue receptor 1a (GHS-R1a). Mechanistic work may evaluate binding or interaction profiles, second-messenger changes, protein phosphorylation, transcriptional responses, metabolic flux, or other endpoints appropriate to the compound class. This multi-component presentation is intended for controlled combination-pathway studies. Researchers should evaluate each constituent and the combined system with suitable controls; the presence of multiple compounds does not establish synergy. These pathways are context dependent: activity observed in one assay does not establish an outcome in another model. Published studies have explored dose-response relationships and pathway cross-talk under controlled laboratory conditions, but results should be treated as experimental observations rather than guaranteed effects. Suitable negative, vehicle, comparator, and time-course controls are important when distinguishing compound-specific responses from background variation.

Research Areas

  • GHRH receptor signaling
  • Growth-hormone pulse models
  • GHS-R1a pharmacology
  • Growth-hormone-axis research

Product Highlights

  • Product-specific classification: multi-component peptide research blend
  • Laboratory vial presentation
  • Clearly identified for catalogue and laboratory handling
  • Individually packaged to support organized inventory
  • Batch identification where applicable
  • Intended for qualified laboratory research

Technical Information

Product Name Blend: CJC1295 NO DAC 5mg + Ipamorelin 5mg
Core Compound CJC 1295 NO DAC + Ipamorelin
Research Classification Multi-Component Peptide Research Blend
Product Form Peptide Blend Material
Container Laboratory Vial
Appearance Refer to the product label or batch documentation
Storage Follow product label and batch documentation
Brand PEPLUS

Storage and Handling

Store according to the product label and accompanying batch documentation. Protect from excessive heat, moisture, and direct light. Keep the container securely closed when not in use. Confirm product-specific conditions before storage or experimental handling. Use appropriate laboratory controls and personal protective measures consistent with institutional procedures. This section does not provide preparation, administration, or human-use instructions.

Quality and Traceability

PEPLUS uses controlled handling and consistent catalogue practices designed to support clear product identification. Vials are labeled for organized laboratory inventory, with batch identification provided where applicable. Any analytical specification should be evaluated against the label or batch documentation supplied with the specific item; no unlisted purity, sterility, certification, or test result is implied.

Shipping and Packaging

The product is packaged to reduce physical damage during transit and to preserve clear identification. Temperature-conscious or insulated packaging may be used when appropriate for the product and shipping route. Researchers should inspect the received package and follow the product label for storage.

Frequently Asked Questions

What type of research material is Blend: CJC1295 NO DAC 5mg + Ipamorelin 5mg?

It is classified as multi-component peptide research blend. This multi-component presentation is intended for controlled combination-pathway studies. Researchers should evaluate each constituent and the combined system with suitable controls; the presence of multiple compounds does not establish synergy.

Which biochemical system is commonly examined?

Research commonly focuses on CJC 1295 NO DAC: GHRH receptor signaling without a drug-affinity-complex extension; Ipamorelin: growth hormone secretagogue receptor 1a (GHS-R1a).

How is the product supplied?

PEPLUS supplies this catalogue item in a clearly identified laboratory vial. Refer to the label for the specific form and quantity.

How should the unopened vial be stored?

Store according to the product label and accompanying batch documentation. Protect from excessive heat, moisture, and direct light. Keep the container securely closed when not in use.

Is this product intended for human use?

No. It is solely a laboratory research material and is not intended for human consumption or any clinical, diagnostic, therapeutic, or veterinary application.

Research Use Only

FOR RESEARCH USE ONLY. This product is intended solely for laboratory and scientific research by qualified professionals. It is not intended for human consumption, therapeutic use, diagnostic use, or veterinary use. The purchaser is responsible for compliance with applicable laws, regulations, and institutional policies.

Specification

(5mg+5mg)/vial*10 vials

Reviews

There are no reviews yet.

Be the first to review “Blend: CJC1295 NO DAC 5mg + Ipamorelin 5mg”

Your email address will not be published. Required fields are marked *

0
    0
    Your Cart
    Empty CartYour cart is emptyReturn to Shop
    Secure Checkout
    Fast Shipping
    Easy Returns